C1q binding to platelets induced by monoclonal antibodies and immune complexes-a flow cytometric analysis.

In recent years there has been a growing interest in measurement of platelet activation. Fluorescence-activated flow cytometry has a high sensitivity and allows the study of whole blood. Platelet-bound fibrinogen, thrombospondin, the alpha-granule protein GMP 140 (CD62) and the fibrinogen receptor have been used as markers for platelet activation utilising fluorescence-labelled antibodies. However, when a labelled antibody used in flow cytometry reacts with the antigen, an immune complex is formed. We have shown that immune complexes containing mouse or rabbit IgG, but not chicken IgG, causes platelet activation. Several monoclonal antibodies directed towards platelet glycoprotein receptors also activate platelets. Suggested potential mechanisms have been direct receptor activation, FcR mediated activation and complement activation. We demonstrate that the activation in platelet-rich plasma by the monoclonal anti-GPIb antibody AN51 could not be prevented by antibodies towards the Fc-receptor, but the antibody induced an extensive binding of C1q. The findings suggest that the complement system has an important role in platelet activation. We would suggest that monoclonal antibodies intended for use in measuring platelet activation should be screened for induction of C1q and C5 binding to the platelets. Chicken antibodies are favourable for the measurement of platelet bound plasma proteins as they do not induce platelet activation.

[1]  T. Lindahl,et al.  Chicken antibodies: a tool to avoid interference by complement activation in ELISA. , 1992, Journal of immunological methods.

[2]  T. Lindahl,et al.  Studies of Fibrinogen Binding to Platelets by Flow Cytometry: An Improved Method for Studies of Platelet Activation , 1992, Thrombosis and Haemostasis.

[3]  J. Kelton,et al.  Investigation of the mechanisms of monoclonal antibody-induced platelet activation , 1991 .

[4]  R. Carroll,et al.  Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (FcγRII) , 1991 .

[5]  J. Esser,et al.  Circulating activated platelets in myeloproliferative disorders. , 1991, Thrombosis research.

[6]  M. Bryckaert,et al.  Increased intraplatelet levels of platelet‐derived growth factor and transforming growth factor‐β in patients with myelofibrosis with myeloid metaplasia , 1991, British journal of haematology.

[7]  T. Warkentin,et al.  Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for the detection of platelet activation , 1990, British journal of haematology.

[8]  E. Peerschke,et al.  Platelet C1q receptor interactions with collagen- and C1q-coated surfaces. , 1990, Journal of immunology.

[9]  G. Anderson,et al.  Signal transduction by the platelet Fc receptor. , 1990, Blood.

[10]  R. Carroll,et al.  Extensive C1q-complement initiated lysis of human platelets by IgG subclass murine monoclonal antibodies to the CD9 antigen. , 1990, Thrombosis research.

[11]  D. Tschoepe,et al.  Evidence for abnormal platelet glycoprotein expression in diabetes mellitus , 1990, European journal of clinical investigation.

[12]  W. Ouwehand,et al.  Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage , 1990, Transfusion.

[13]  P. Sims,et al.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.

[14]  J. Sjöquist,et al.  Quantification of circulating immune complexes by chicken anti-C4 micro ELISA. , 1988, Journal of clinical & laboratory immunology.

[15]  C. Mueller-Eckhardt,et al.  Redistribution of platelet glycoproteins induced by allo- and autoantibodies. , 1987, Thrombosis and haemostasis.

[16]  J. Hoxie,et al.  Detection of activated platelets in whole blood using activation- dependent monoclonal antibodies and flow cytometry , 1987 .

[17]  J. George,et al.  Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. , 1986, The Journal of clinical investigation.

[18]  C. Anderson,et al.  Human platelet Fc receptor for immunoglobulin G. Identification as a 40,000-molecular-weight membrane protein shared by monocytes. , 1985, The Journal of clinical investigation.

[19]  J. Hoxie,et al.  Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. , 1985, The Journal of biological chemistry.

[20]  K. J. van der Merwe,et al.  Improvements in the isolation of IgY from the yolks of eggs laid by immunized hens. , 1985, Immunological investigations.

[21]  Robert B Sim,et al.  Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q. , 1977, The Biochemical journal.